European Archives - Page 484 of 1280 - European Medical Journal

Long-Term Outcomes of Penile Squamous Cell Carcinoma

New research analyses outcomes in males over and under 50 years of age with penile cancer. This investigation highlights the importance of public awareness and patient education for disease prevention, early detection, and management in the near future.

EMJ Neurology 12 [Supplement 1] 2024

Non-seizure symptoms in Dravet and Lennox-Gastaut syndromes can affect speech, gait, appetite, mood, development, and sleep and impact…

Impact of Non-Seizure Symptoms in Dravet Syndrome and Lennox-Gastaut Syndrome

Non-seizure symptoms in Dravet and Lennox-Gastaut syndromes can affect speech, gait, appetite, mood, development, and sleep and impact…

Ovarian Stimulation for In Vitro Fertilisation

Our latest reproductive health webinar provides insight into the world of in vitro fertilisation (IVF). Useful treatment information is…

Tuning in to Renal Dysfunction - Part 1

This week, we are joined by George Bakris, Director of the Comprehensive Hypertension Center at the University of Chicago, to discuss everything from music to dialysis.

Deteriorating Diagnosis Times for Endometriosis

Females are waiting almost 9 years for an endometriosis diagnosis, and feel their symptoms are commonly dismissed by healthcare professionals. This study aims to raise awareness this Endometriosis Awareness Month (March 2024).

Latest Spring Journal Out Now!

Explore this new issue showcasing multidisciplinary healthcare and other pertinent topics, including contraceptive use among females with…

Natural Language Processing Identifies Low-Risk Pulmonary Embolism

Researchers have developed a natural language processing based model, which utilises information from radiology reports to accurately identify patients with suspected pulmonary embolism in the emergency department.

Non-Factor Therapies in Current Clinical Practice

The 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) took place on 6th–9th February 2024 in…

Sparsentan for treatment of immunoglobulin A nephropathy: Latest study results

In patients with immunoglobulin A nephropathy, use of the endothelin 1 Type A/Ang II subtype 1 receptor antagonist sparsentan can decrease proteinuria and preserve kidney function